Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Introduction: The availability of easily accessible continuous glucose monitoring (CGM) metrics can improve glycemic control in diabetes, and they may even become a viable alternative to hemoglobin A1c (HbA1c) laboratory tests in the next years. The REALISM-T1D study (REAl-Life glucoSe Monitoring in Type 1 Diabetes) was aimed at contributing, with real-world data, to a deeper understanding of these metrics, including the time in range (TIR)–HbA1c relationship, to facilitate their adoption by diabetologists in everyday practice. Research design and methods: 70 adults affected by type 1 diabetes were monitored for 1 year by means of either flash (FGM) or real-time (rtCGM) glucose monitoring devices. Follow-up visits were performed after 90, 180 and 365 days from baseline and percentage TIR 70–180 evaluated for the 90-day time period preceding each visit. HbA1c tests were also carried out in the same occasions and measured values paired with the corresponding TIR data. Results: A monovariate linear regression analysis confirms a strong correlation between TIR and HbA1c as found in previous studies, but leveraging more homogeneous data (n=146) collected in real-life conditions. Differences were determined between FGM and rtCGM devices in Pearson’s correlation (r FGM=0.703, r rtCGM=0.739), slope (β 1,FGM=−11.77, β 1,rtCGM=−10.74) and intercept (β 0,FGM=141.19, β 0,rtCGM=140.77) coefficients. Normality of residuals and homoscedasticity were successfully verified in both cases. Conclusions: Regression lines for two patient groups monitored through FGM and rtCGM devices, respectively, while confirming a linear relationship between TIR and A1c hemoglobin (A1C) in good accordance with previous studies, also show a statistically significant difference in the regression intercept, thus suggesting the need for different models tailored to device characteristics. The predictive power of A1C as a TIR estimator also deserves further investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A 10-to 14-day CGM assessment of TIR, with CGM wear of 70% or higher, and other CGM metrics can be used to assess glycemic status and are useful in clinical management (22)(23)(24)(25)(26).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete Multivariate Analysis: Theory and Practice.
Beniger, J. R., Bishop, Y. M. M., Feinberg, S. E., Holland, P. W., Light, R. J., & Mosteller, F. (1975) · Contemporary Sociology · doi:10.2307/2063625 · Cited by 5,108
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237 · cited 2×
“…the procedures to calibrate their sensors and upload CGM data (in the case they were requested to do so themselves, in particular with rtCGM sensors) during a preliminary visit and a subsequent 2-week training, and then CGM was started and data seamlessly collected for a full 1-year time period.”
InfluentialAsymptotic Theory of Certain "Goodness of Fit" Criteria Based on Stochastic Processes
Anderson, T. W., & Darling, D. A. (1952) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729437 · Cited by 3,542
EDF Statistics for Goodness of Fit and Some Comparisons
Stephens, M. A. (1974) · Journal of the American Statistical Association · doi:10.2307/2286009 · Cited by 3,186
EDF Statistics for Goodness of Fit and Some Comparisons
Stephens, M. A. (1974) · Journal of the American Statistical Association · doi:10.1080/01621459.1974.10480196 · Cited by 3,166
Koziol, J. A., D'Agostino, R. B., & Stephens, M. A. (1987) · Journal of Educational Statistics · doi:10.2307/1165059 · Cited by 1,982
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Blonde, L., Khunti, K., Harris, S. B., Meizinger, C., & Skolnik, N. S. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0805-y · Cited by 714
Some Tests for Homoscedasticity
Goldfeld, S. M., & Quandt, R. E. (1965) · Journal of the American Statistical Association · doi:10.1080/01621459.1965.10480811 · Cited by 712
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684 · cited 1×
“Patients were first given instructions about the use of the prescribed devices and the procedures to calibrate their sensors and upload CGM data (in the case they were requested to do so themselves, in particular with rtCGM sensors) during a preliminary visit and a subsequent 2-week training, and…”
Discrete Multivariate Analysis Theory and Practice
(2007) · Springer eBooks · doi:10.1007/978-0-387-72806-3 · Cited by 675
The relationships between time in range, hyperglycemia metrics, and HbA1c
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479 · cited 4×
“Differently from other works based on randomized studies, such as Vigersky and McMahon, 17 Beck et al , 18 and Petersson et al , 19 our investigations were based on pure 1-year observations of 70 patients with type 1 diabetes adopting CGM in Emerging technologies, pharmacology and therapeutics…”
InfluentialThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
The relationship of hemoglobin A1C to time-in-range in patients with diabetes
Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
Riddlesworth, T. D., Beck, R. W., Gal, R. L., Connor, C. G., Bergenstal, R. M., Lee, S., & Willi, S. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0455 · Cited by 266
Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.015 · Cited by 239
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017) · Electronics · doi:10.3390/electronics6030065 · Cited by 237
A View Beyond HbA1c: Role of Continuous Glucose Monitoring
Chehregosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F., & Ismail-Beigi, F. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0619-1 · Cited by 235
Wright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
Improving the clinical value and utility of CGM systems: issues and recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4463-4 · Cited by 148
Glycemic variability: how to measure and its clinical implication for type 2 diabetes
Umpierrez, G. E., & P. Kovatchev, B. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.09.010 · Cited by 148
Some Tests for Homoscedasticity
Goldfeld, S. M., & Quandt, R. E. (1965) · Journal of the American Statistical Association · doi:10.2307/2282689 · Cited by 127
Lee, J. E. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.2.74 · Cited by 106
Johnson, M. L., Martens, T. W., Criego, A. B., Carlson, A. L., Simonson, G. D., & Bergenstal, R. M. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0034 · Cited by 104
Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
Beyond A1C Writing Group (2018) · Diabetes Care · doi:10.2337/dci18-0010 · Cited by 86
Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study
Petersson, J., Åkesson, K., Sundberg, F., & Särnblad, S. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12817 · Cited by 74
Wood, A., O'Neal, D., Furler, J., & Ekinci, E. I. (2018) · Internal Medicine Journal · doi:10.1111/imj.13770 · Cited by 67
Current Diabetes Technology: Striving for the Artificial Pancreas
Allen, N., & Gupta, A. (2019) · Diagnostics · doi:10.3390/diagnostics9010031 · Cited by 65
The Future of Continuous Glucose Monitoring
Garg, S. K., & Akturk, H. K. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0097 · Cited by 34
Glycemic Variability: Looking Beyond the A1C
Tylee, T. S., & Trence, D. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.3.149 · Cited by 28
Glucose Monitoring: An Important Tool for Improving Glucose Control and Reducing Hypoglycemia
Garg, S. K. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0008 · Cited by 21
Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data
Pleus, S., Kamecke, U., Link, M., Haug, C., & Freckmann, G. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817733095 · Cited by 17
Ekhlaspour, L., Tabatabai, I., & Buckingham, B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819851790 · Cited by 17
105-LB: Does HbA1c Accurately Predict Time-in-Range?
Dixon, R. F., MILLER, D. P., Majithia, A. R., Lee, A. A., ROBERTSON, S., GERMANOS, M. J., & Zisser, H. (2019) · Diabetes · doi:10.2337/db19-105-lb · Cited by 4
Cited by
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Metadata
- Authors
- Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G.
- Affiliations
- University of Turin (IT)
- Institute of Electronics, Information and Telecommunication Engineering, CNR IEIIT, Torino, Piemonte, Italy
- Institute of Electronics, Computer and Telecommunication Engineering (IT)
- Endocrinology, Ospedale Molinette, Torino, Piemonte, Italy
- Corresponding author
- Grassi, Giorgio
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2021-01
- Volume
- 9
- Issue
- 1
- Pages
- e001045
- ISSN
- 2052-4897 (ISSN-L)
- PMC
- PMC7849891
- OpenAlex
- W3123398944
- Cited by
- 34
- References
- 33
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 6
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, HbA1c, type 1 diabetes, continuous glucose monitoring, flash glucose monitoring, real-time glucose monitoring, glycemic control
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.